Biohaven Pharmaceutical Holding Company Ltd. Skyrocketed
Wed, Oct 05, 2022 at 07:53 PM
Biohaven Pharmaceutical Holding Company Ltd. (BHVN:NYSE) shot up at $12.25, a gain of 47.6%. On Wed, Oct 05, 2022, BHVN:NYSE touched a New 2-Week Intraday Low of $8.25. The stock appeared on our News Catalysts scanner on Tue, Oct 04, 2022 at 07:30 PM in the 'MISCELLANEOUS' category. From Wed, Sep 21, 2022, the stock recorded 60.00% Up Days and 54.55% Green Days
About Biohaven Pharmaceutical Holding Company Ltd. (BHVN:NYSE)
Biohaven Pharmaceutical Holding Co Ltd is a clinical-stage biopharmaceutical company with a portfolio of innovative, late-stage product candidates targeting neurological diseases, including rare disorders.
Top 10 Gainers:
- Chardan NexTech Acquisition 2 Corp. (CNTQ:NASDAQ), 102.63%
- Nauticus Robotics Inc. (KITT:NASDAQ), 96.27%
- Pineapple Holdings Inc Com (PEGY:NASDAQ), 93.01%
- Top Ships Inc. (TOPS:NASDAQ), 81.95%
- SHF Holdings Inc Cl A (SHFS:NASDAQ), 48.91%
- Biohaven Pharmaceutical Holding Company Ltd. (BHVN:NYSE), 47.59%
- FOXO Technologies Inc. Class A (FOXO:NYSEMKT), 41.23%
- Super League Gaming, Inc. (SLGG:NASDAQ), 34.35%
- Salarius Pharmaceuticals, Inc. (SLRX:NASDAQ), 27.76%
- Globus Maritime Limited (GLBS:NASDAQ), 26.67%